# AATT (NCT00984412)

> Allo-Allo Tandem Bone Marrow Transplant (BMT)

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: refractory acute leukemia

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00984412
- Phase: PHASE1, PHASE2
- Status: UNKNOWN
- Sponsor: Hadassah Medical Organization
- Conditions: Refractory Acute Leukemia
- Interventions: Allogeneic hematopoietic stem-cell-transplantation
- Enrollment: 15
- Primary outcome: Transplant-related mortality (TRM) of SCT II.
- Primary outcome: Transplant-related toxicity (TRT) of SCT II.

## Indexed commentary on AATT so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 4
- YouTube: 2
- Podcasts: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=aatt-nct00984412